BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Berna Biotech Paying EUR279M In Cash, Shares For Rhein Biotech

May 24, 2002
By Cormac Sheridan

Speedel Moves SPP 301 Into Phase II Pilot Studies

May 22, 2002
By Cormac Sheridan

Speedel Moves SPP 301 Into Phase II Pilot Studies

May 22, 2002
By Cormac Sheridan

Denmark's Genesto Raises DKK40M Through First Round

May 15, 2002
By Cormac Sheridan

CMC Biotech Raises DKK300M For Contract Manufacturing

May 15, 2002
By Cormac Sheridan

ESBATech Raises CHF10.5M For Yeast Cell Screening Assays

May 15, 2002
By Cormac Sheridan

Denmark's Genesto Raises DKK40M Through First Round

May 15, 2002
By Cormac Sheridan

ESBATech Raises CHF10.5M For Yeast Cell Screening Assays

May 15, 2002
By Cormac Sheridan

CMC Biotech Raises DKK300M For Contract Manufacturing

May 15, 2002
By Cormac Sheridan

Personal Chemistry Purchases ESyTech To Extend Platform

May 8, 2002
By Cormac Sheridan
Previous 1 2 … 325 326 327 328 329 330 331 332 333 334 335 336 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 5, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Illustration of chromosome unraveling down to the DNA

    First phase of synthetic human genome project successfully completes

    BioWorld
    The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • 3D Euro symbol

    Laigo raises €11.5M seed money for targeted protein degradation

    BioWorld Science
    Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing